Viemed Healthcare Inc (VMD)
8.18
-0.01
(-0.12%)
USD |
NASDAQ |
May 03, 16:00
8.19
+0.01
(+0.12%)
After-Hours: 20:00
Viemed Healthcare Research and Development Expense (Quarterly): 0.651M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.651M |
| September 30, 2023 | 0.593M |
| June 30, 2023 | 0.758M |
| March 31, 2023 | 0.78M |
| December 31, 2022 | 0.722M |
| September 30, 2022 | 0.67M |
| June 30, 2022 | 0.672M |
| March 31, 2022 | 0.632M |
| December 31, 2021 | 0.612M |
| September 30, 2021 | 0.576M |
| June 30, 2021 | 0.583M |
| March 31, 2021 | 0.339M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.395M |
| September 30, 2020 | 0.243M |
| June 30, 2020 | 0.271M |
| March 31, 2020 | 0.174M |
| December 31, 2019 | 0.203M |
| September 30, 2019 | 0.208M |
| June 30, 2019 | 0.203M |
| March 31, 2019 | 0.234M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.174M
Minimum
Mar 2020
0.78M
Maximum
Mar 2023
0.4887M
Average
0.583M
Median
Jun 2021
Research and Development Expense (Quarterly) Benchmarks
| Cutera Inc | 4.564M |
| Dynatronics Corp | -- |
| Stereotaxis Inc | 2.212M |
| Electromed Inc | 0.107M |
| Myomo Inc | 0.878M |